None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Babies of either sex in the age group 7 days to 6 months, weighing 2500 grams or more (greater than or equal to 2500 g) at the time of birth 2. APGAR score > 7 at 1 and 5 minutes with no resuscitation required at birth 3. Exclusively breast-fed babies up to the age of 4 months and babies of age between 4 - 6 months who were top feed along with breast-feed 4. Medically stable babies without any requirement of drugs interventions/ procedures/ nutraceutical/ health supplement 5. Parents of the infant willing to sign the informed consent
Exclusion criteria
Exclusion criteria: 1. Sick infants, infants with muscular trauma, skin infections, congenital anomalies or neuromuscular disorders 2. Known hypersensitivity to study product or any ingredient in the study product 3. Concomitant use medications known to adversely interact with the study drug or its related ingredients 4. Parents of the infants not willing to come for follow-up when required 5. Subjects participating in any other clinical trials
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the efficacy of Dabur Lal Tail massage on growth in neonates and infants in comparison with placebo massage and no massageTimepoint: 10 weeks (5 follow up visits) | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess the safety profile of Dabur Lal TailTimepoint: 10 weeks (5 follow up visits) | — |
Countries
India
Contacts
Dabur India Limited